Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance.

Abstract:

OBJECTIVE:To investigate the prevalence and characteristics of anti-endothelial cell antibodies (AECA) in a large cohort of patients with several well defined systemic autoimmune diseases, in order to determine their relationship with the clinical and laboratory features of these diseases. METHODS:Clinical and laboratory features of 216 consecutive Caucasian patients were prospectively studied. One hundred and seven patients had been diagnosed as having a primary systemic vasculitis-specifically, 39 had temporal arteritis (TA), 25 polyarteritis nodosa (PAN), 9 Wegener's granulomatosis (WG), and 34 Behcet's disease (BD)-, 90 patients had systemic lupus erythematosus (SLE), and 19 had a primary Sjogren's syndrome (SS). The AECA were determined by ELISA. RESULTS:One hundred and four (48%) patients with systemic autoimmune diseases were found to have a positive titre of AECA. Specifically, AECA were detected in 41 (38%) patients with a primary systemic vasculitis (13 (33%) with TA, 14 (56%) with PAN, 5 (56%) with WG and 9 (26%) with BD), in 58 (63%) patients with SLE, and in 5 (26%) patients with a primary SS. In patients with a primary systemic vasculitis, those with AECA were found to have an increased prevalence of disease activity (P < 0.05). In SLE patients, those with AECA were found to have an increased prevalence of vascular lesions (P < 0.05), lupus nephropathy (P < 0.05), and anticardiolipin antibodies (aCL) (P < 0.001). CONCLUSIONS:Patients with systemic autoimmune diseases have a high prevalence of AECA and they are associated with the presence of vascular lesions, nephropathy, and aCL in SLE, as well as with disease activity in several primary systemic vasculitis (TA, PAN, WG and BD).

journal_name

Lupus

journal_title

Lupus

authors

Navarro M,Cervera R,Font J,Reverter JC,Monteagudo J,Escolar G,López-Soto A,Ordinas A,Ingelmo M

doi

10.1177/096120339700600608

subject

Has Abstract

pub_date

1997-01-01 00:00:00

pages

521-6

issue

6

eissn

0961-2033

issn

1477-0962

journal_volume

6

pub_type

杂志文章

相关文献

LUPUS文献大全
  • European registry of babies born to mothers with antiphospholipid syndrome: a result update.

    abstract::The registry is a prospective, European, multicentric, longitudinal study, which follows a cohort of children born to mothers with antiphospholipid syndrome (APS). It was started in 2003. In this report, we update the results obtained from the study of 110 mothers and 112 children (two twin births). Eighty per cent of...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203309106951

    authors: Boffa MC,Lachassinne E,Boinot C,De Carolis S,Rovere-Querini P,Avcin T,Biasini-Rebaioli C,Le Toumelin P,Aurousseau MH,Tincani A

    更新日期:2009-09-01 00:00:00

  • Antiphospholipid antibodies and myocardial infarction.

    abstract::In prospective studies, increased levels of cardiolipin-biding antibodies and autoantibodies to oxidized low-density lipoprotein (LDL) have been observed in patients with myocardial infarction (MI). These findings suggest that antiphospholipid antibodies may contribute to the development of MI. The 'oxidative-modifica...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339800700229

    authors: Vaarala O

    更新日期:1998-01-01 00:00:00

  • Human Fc gamma receptor IIA (FcgammaRIIA) genotyping and association with systemic lupus erythematosus (SLE) in Chinese and Malays in Malaysia.

    abstract::SLE is an autoimmune and polygenic disorder characterized by an accumulation and deposition of immune complexes. Several studies have indicated differential impact of FcgammaR polymorphism genotypes in different ethnic groups studied. The Fc receptor for IgG class IIA gene (FcgammaRIIA) occurs in two allelic forms. Th...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399678847876

    authors: Yap SN,Phipps ME,Manivasagar M,Tan SY,Bosco JJ

    更新日期:1999-01-01 00:00:00

  • PRISM (Pictorial Representation of Illness and Self Measure)- a novel visual method to assess the global burden of illness in patients with systemic lupus erythematosus.

    abstract:OBJECTIVE:For patients with chronic illnesses the global burden of illness is a crucial health measure hitherto neglected in research studies and clinical practice. We tested the application and validity of PRISM (Pictorial Representation of Illness and Self-Measure), a novel visual method for assessing the burden of i...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120300678828479

    authors: Büchi S,Villiger P,Kauer Y,Klaghofer R,Sensky T,Stoll T

    更新日期:2000-01-01 00:00:00

  • Lupus nephritis in Latin American patients: 10-year results from a single medical center in Argentina.

    abstract:INTRODUCTION:Several studies have shown that Hispanic patients generally experience a worse renal prognosis than non-Hispanic white patients with lupus. To date, there is no report on American College of Rheumatology (ACR) renal response criteria (ACR-RRC) in patients from Latin America. OBJECTIVE:To evaluate treatmen...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315600537

    authors: Vinicki JP,Paniego FM,De Rosa G,Dubinsky D,Laborde HA,Marini A,Nasswetter G

    更新日期:2016-02-01 00:00:00

  • Headaches in patients with systemic lupus erythematosus: a comparative study.

    abstract::The incidence and nature of headaches in 85 systemic lupus erythematosus (SLE) patients attending an outpatient clinic were studied and compared to those experienced by 61 nurses. The two groups were similar in age, sex and ethnicity. Test-retest assessment of reliability gave both groups 95% confidence limits of 0.09...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu1050oa

    authors: Whitelaw DA,Hugo F,Spangenberg JJ,Rickman R

    更新日期:2004-01-01 00:00:00

  • Chronic or recurrent headache in patients with systemic lupus erythematosus: a case control study.

    abstract::Controversy exists concerning the prevalence of headache in systemic lupus erythematosus (SLE) and its importance as a neuropsychiatric manifestation, especially when it occurs independently of disease activity and with the typical characteristics of primary chronic headache. Most reports to date have either studied b...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399678847443

    authors: Fernández-Nebro A,Palacios-Muñoz R,Gordillo J,Abarca-Costalago M,De Haro-Liger M,Rodríguez-Andreu J,González-Santos P

    更新日期:1999-01-01 00:00:00

  • Preliminary study on the changes of ovarian reserve, menstruation, and lymphocyte subpopulation in systemic lupus erythematosus (SLE) patients of childbearing age.

    abstract::Objective The main aim of this study was to investigate the ovarian reserve, menstruation, and lymphocyte subpopulation in systemic lupus erythematosus (SLE) patients of childbearing age. Methods We enrolled 40 SLE patients of childbearing age and 40 age-matched healthy controls. Anti-Müllerian hormone (AMH) was teste...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317726378

    authors: Gao H,Ma J,Wang X,Lv T,Liu J,Ren Y,Li Y,Zhang Y

    更新日期:2018-03-01 00:00:00

  • Identification and characterization of a new human DNA reactive monoclonal antibody and a common idiotype, WRI 176 Id beta.

    abstract::We describe a human monoclonal antibody designated WRI 176 beta and a common idiotype that it carries. This antibody was derived from the spleen of a patient with SLE. WRI 176 is an IgM kappa monoclonal reacting with ssDNA, dsDNA, poly(dT) and it is likely that mAb WRI 176 beta is a representative of the so-called nat...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339400300105

    authors: Blanco F,Longhurst C,Watts R,Kalsi J,Wiloch HW,Youinou P,Latchman DS,Isenberg DA

    更新日期:1994-02-01 00:00:00

  • Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile.

    abstract::We report the experience from the Antiphospholipid Antibodies (aPL) Regional Consortium in northwest Italy, meant to support clinical research and foster collaboration among health professionals regarding the diagnosis and management of antiphospholipid syndrome (APS) patients. This cohort-study (APS Piedmont Cohort) ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312446974

    authors: Bertero MT,Bazzan M,Carignola R,Montaruli B,Silvestro E,Sciascia S,Vaccarino A,Baldovino S,Roccatello D,Antiphospholipid Piedmont Consortium.

    更新日期:2012-06-01 00:00:00

  • Antiphospholipid antibody-mediated effects in an arterial model of thrombosis are dependent on Toll-like receptor 4.

    abstract::Patients with antiphospholipid syndrome (APS) produce antiphospholipid antibodies (aPL) and develop vascular thrombosis that may occur in large or small vessels in the arterial or venous beds. On the other hand, many individuals produce aPL and yet never develop thrombotic events. Toll-like receptor 4 (TLR4) appears t...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315603146

    authors: Laplante P,Fuentes R,Salem D,Subang R,Gillis MA,Hachem A,Farhat N,Qureshi ST,Fletcher CA,Roubey RA,Merhi Y,Thorin É,Levine JS,Mackman N,Rauch J

    更新日期:2016-02-01 00:00:00

  • High prevalence of infections in patients with systemic lupus erythematosus and pulmonary haemorrhage.

    abstract::The main objective of this study is to describe the presence of infections in patients with pulmonary haemorrhage and systemic lupus erythematosus. Patients with systemic lupus erythematosus and pulmonary haemorrhage were thoroughly evaluated in the first 48 hours with imaging plus bronchoscopy and bronchoalveolar flu...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307086930

    authors: Rojas-Serrano J,Pedroza J,Regalado J,Robledo J,Reyes E,Sifuentes-Osornio J,Flores-Suárez LF

    更新日期:2008-04-01 00:00:00

  • Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves.

    abstract:OBJECTIVE:To examine the potential immunologic mechanism and involvement of antiphospholipid antibodies in the pathogenesis of heart valve lesions in patients with the antiphospholipid syndrome (APS). METHODS:Immunoperoxidase and immunofluorescence staining methods were used to evaluate 13 heart valve specimens derive...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339600500306

    authors: Ziporen L,Goldberg I,Arad M,Hojnik M,Ordi-Ros J,Afek A,Blank M,Sandbank Y,Vilardell-Tarres M,de Torres I,Weinberger A,Asherson RA,Kopolovic Y,Shoenfeld Y

    更新日期:1996-06-01 00:00:00

  • In vivo models of thrombosis for the antiphospholipid syndrome.

    abstract::Utilizing this unique animal model of thrombosis we demonstrated that human (IgG, IgM or IgA) polyclonal and monoclonal antiphospholipid antibodies derived from APS patients have a significant enhancing effect on thrombus formation. This effect is reversed by treatment of the mice with hydroxychloroquine (plaquenil). ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339600500524

    authors: Pierangeli SS,Harris EN

    更新日期:1996-10-01 00:00:00

  • Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention.

    abstract::Systemic lupus erythematosus (SLE) is an autoantibody and immune complex mediated disease. However, it is the ensuing inflammatory process that leads to irreversible organ damage. In fact several murine models of SLE suggest that this inflammatory organ damage can be prevented even in the presence of autoantibodies. G...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203303lu1024oa

    authors: Aringer M,Smolen JS

    更新日期:2004-01-01 00:00:00

  • Evaluation of polymorphic variants in apoptotic genes and their role in susceptibility and clinical progression to systemic lupus erythematosus.

    abstract::Background Systemic lupus erythematosus (SLE) is an autoimmune disease marked by the disruption of the immune homeostasis. Patients exhibit a wide range of clinical manifestations, and environmental and genetic factors are involved in SLE pathogenesis. Evidence suggests that abnormalities in the cellular and molecular...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316678671

    authors: Glesse N,Vianna P,Paim LMG,Matte MCC,Aguiar AKK,Palhano PL,Monticielo OA,Brenol CV,Xavier RM,Chies JAB

    更新日期:2017-06-01 00:00:00

  • Vitamin D insufficiency in a large female SLE cohort.

    abstract::The objective of this study was to determine the vitamin D status and its relationship with disease and therapy features and with bone mineral density in women with systemic lupus erythematosus. Non-pregnant systemic lupus erythematosus women with dual-energy X-ray absorptiometry and vitamin D measurements performed b...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309345775

    authors: Toloza SM,Cole DE,Gladman DD,Ibañez D,Urowitz MB

    更新日期:2010-01-01 00:00:00

  • Sexual dysfunction in Egyptian females with systemic lupus erythematosus: a cross sectional study.

    abstract:OBJECTIVES:Sexual dysfunction in systemic lupus erythematous (SLE) patients is an important issue to be tackled. We aimed to study the prevalence of sexual dysfunction in SLE women and detect its association with depression, functional disability and quality of life. METHODS:This study included 94 SLE females. Ninety-...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320935518

    authors: Dorgham D,Haggag HM,Attia DH

    更新日期:2020-08-01 00:00:00

  • Autoimmunity, infertility and assisted reproductive technologies.

    abstract::Despite strongly held opinions, a trustworthy scientific basis for most statements about autoimmunity, autoimmune diseases and assisted reproductive technologies (ART) does not exist. It is not likely that autoimmunity causes infertility, nor that patients with autoimmune diseases are unusually infertile. When careful...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu2000oa

    authors: Lockshin MD

    更新日期:2004-01-01 00:00:00

  • The blood-brain barrier in systemic lupus erythematosus.

    abstract::Central nervous system (CNS) involvement may occur in 20-70% of systemic lupus erythematosus (SLE) patients where neurological symptoms are overt; this is termed neuropsychiatric lupus or NPSLE. This review summarizes evidence that damage to the brain endothelium forming the blood-brain barrier (BBB) is a contributory...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203303lu501oa

    authors: Abbott NJ,Mendonça LL,Dolman DE

    更新日期:2003-01-01 00:00:00

  • Clinical management of Lupus patients during the COVID-19 pandemic.

    abstract::Severe acute respiratory syndrome coronavirus (SARS-CoV-2), the virus causing Coronavirus disease 2019 (COVID-19), has had a huge impact on health services with a high mortality associated with complications including pneumonia and acute respiratory distress syndrome. Historical evidence suggests that Lupus patients h...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203320961848

    authors: Mason A,Rose E,Edwards CJ

    更新日期:2020-11-01 00:00:00

  • Musculoskeletal involvement in systemic lupus erythematosus.

    abstract::Involvement of the musculoskeletal system is common if not universal in the clinical course of systemic lupus erythematosus (SLE). Joint involvement on the whole does not cause major erosive disease, however, recent developments in musculoskeletal imaging show clearly the presence of significant bony and soft tissue i...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu2021oa

    authors: Zoma A

    更新日期:2004-01-01 00:00:00

  • Diabetes mellitus complicating systemic lupus erythematosus - analysis of the UCL lupus cohort and review of the literature.

    abstract::Systemic lupus erythematosus (SLE) often coexists with other diseases. Diabetes mellitus (DM) is an example and patients with overlap SLE-DM can present with clinical features common to both disorders. In this review, we describe the patients with overlap SLE-DM, focussing on the clinical features common to both disea...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203308091539

    authors: Cortes S,Chambers S,Jerónimo A,Isenberg D

    更新日期:2008-11-01 00:00:00

  • Using the GRADE system in diagnostic strategy: the case of antiphospholipid syndrome.

    abstract::Diagnostic strategy studies commonly focus on the accuracy of tests in diagnosing, and grading this body of evidence is a challenge in itself because (1) standard tools for grading evidence were designed for questions about treatment rather than diagnostic testing; and (2) the clinical usefulness of a diagnostic strat...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314543922

    authors: Mendes de Abreu M,Levy RA,Wahl D

    更新日期:2014-10-01 00:00:00

  • Tumour necrosis factor alpha in systemic lupus erythematosus and anti-DNA autoantibody production.

    abstract::Tumour necrosis factor (TNFalpha) is a cytokine with a wide range of diverse and at times paradoxical effects. These include immunoregulatory, lymphoid organogenesis and pro-inflammatory effects. In recent years, TNFalpha has become a focus of interest more for its inflammatory effects in a number of chronic autoimmun...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203302lu306rr

    authors: Mageed RA,Isenberg DA

    更新日期:2002-01-01 00:00:00

  • Impairment of quality of life in patients with antiphospholipid syndrome.

    abstract:OBJECTIVES:Health-related quality of life (HRQoL) has not been fully explored in antiphospholipid syndrome (APS); therefore, we compared HRQoL between APS patients and the general population and assessed the impact of thromboembolic history. METHODS:HRQoL was measured in a multicentre cohort study by the Medical Outco...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203315580871

    authors: Zuily S,Rat AC,Regnault V,Kaminsky P,Mismetti P,Ninet J,Baillet N,Magy-Bertrand N,Pasquali JL,Lambert M,Pasquier E,Lorcerie B,Lecompte T,Guillemin F,Wahl D,TAC(I)T investigators.

    更新日期:2015-10-01 00:00:00

  • Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity?

    abstract::Neonatal antiphospholipid syndrome (neonatal APS) seems to be exceedingly rare, as the antiphospholipid antibodies (aPL) related thrombosis in the neonatal period. The pathogenesis of perinatal aPL related thrombosis may be explained both by the transplacental passage of the maternal antibodies and by the production o...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203314560207

    authors: De Carolis MP,Salvi S,Botta A,Cocca C,Garufi C,Lanzone A,De Carolis S

    更新日期:2015-03-01 00:00:00

  • Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapy.

    abstract::The pathogenesis and therapy of shrinking lungs syndrome in patients with systemic lupus erythematosus remains controversial. It has been previously reported that corticosteroid treatment can be effective. We report a patient with shrinking lungs syndrome who presented a good response to inhaled beta-agonist therapy. ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600413

    authors: Muñoz-Rodríguez FJ,Font J,Badia JR,Miret C,Barberà JA,Cervera R,Ingelmo M

    更新日期:1997-01-01 00:00:00

  • Interleukin-2 and systemic lupus erythematosus--fifteen years later.

    abstract::Systemic lupus erythematosus (SLE) is a highly heterogeneous disorder in which multiple immunologic abnormalities have been described. In this review, we thoroughly analyse the impaired T cell production of, and response to, interleukin-2 (IL-2) characteristic of patients with SLE. Since it was first reported, several...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120398678920028

    authors: Crispin JC,Alcocer-Varela J

    更新日期:1998-01-01 00:00:00

  • Antiphospholipid antibodies in an in vivo thrombosis model in mice.

    abstract::The mouse model described in this study offers a unique method of determining the characteristics and mechanism(s) of action of aCL antibodies in thrombosis in vivo. In addition, this animal model enables the study of the kinetics of formation and dissolution of thrombus, as well as clot area, to be studied in a dynam...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339400300408

    authors: Pierangeli SS,Harris EN

    更新日期:1994-08-01 00:00:00